Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSISTENT 1: Hylenex in Type 1 Diabetes
NCT01848990Phase 4Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Mar 2013
- Primary completion
- Feb 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started Mar 2013; status: completed.
02
Drugs
hyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01848990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848990.